$142 Million is the total value of Kopp Family Office, LLC's 14 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | Horizon Therapeutics Public Limited Company | $43,393,000 | -24.3% | 544,043 | -0.1% | 30.48% | -1.6% |
| IEFA | Buy | ISHARES TRcore msci eafe | $22,994,000 | -13.1% | 390,722 | +2.6% | 16.15% | +12.9% |
| FIVN | Buy | Five9, Inc. | $15,902,000 | -13.4% | 174,478 | +4.9% | 11.17% | +12.6% |
| JAMF | Buy | JAMF HOLDING CORP | $15,388,000 | -28.1% | 621,243 | +1.1% | 10.81% | -6.5% |
| IEMG | Sell | ISHARES TRcore msci emkt | $14,951,000 | -11.7% | 304,745 | -0.0% | 10.50% | +14.8% |
| VCEL | Buy | Vericel Corporation | $13,924,000 | -34.1% | 552,973 | +0.0% | 9.78% | -14.4% |
| NEO | Buy | NeoGenomics Inc. | $13,166,000 | -32.9% | 1,615,513 | +0.1% | 9.25% | -12.7% |
| MITK | Buy | MITEK SYS INC | $2,320,000 | -33.3% | 251,055 | +5.9% | 1.63% | -13.3% |
| ISTB | ISHARES TRcore 1 5 yr usd | $106,000 | -1.9% | 2,228 | 0.0% | 0.07% | +27.6% | |
| IVV | ISHARES TRcore s&p500 etf | $89,000 | -16.0% | 234 | 0.0% | 0.06% | +10.5% | |
| IAGG | ISHARES TRcore intl aggr | $43,000 | -4.4% | 862 | 0.0% | 0.03% | +25.0% | |
| IMTB | ISHARES TRcr 5 10 yr etf | $37,000 | -5.1% | 834 | 0.0% | 0.03% | +23.8% | |
| IJH | ISHARES TRcore s&p mcp etf | $28,000 | -15.2% | 122 | 0.0% | 0.02% | +11.1% | |
| IJR | ISHARES TRcore s&p scp etf | $16,000 | -11.1% | 169 | 0.0% | 0.01% | +10.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NeoGenomics Inc. | 16 | Q3 2023 | 90.1% |
| Vericel Corporation | 16 | Q3 2023 | 14.5% |
| Five9, Inc. | 16 | Q3 2023 | 11.2% |
| ISHARES TR | 13 | Q3 2023 | 16.7% |
| ISHARES TR | 13 | Q3 2023 | 10.6% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.1% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
| ISHARES TR | 13 | Q3 2023 | 0.0% |
View Kopp Family Office, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| RTI Surgical Holdings, Inc. | July 07, 2020 | ? | ? |
| NEOGENOMICS INC | January 07, 2020 | 4,844,625 | 4.6% |
| OCLARO, INC. | January 04, 2019 | ? | ? |
| SUPERCONDUCTOR TECHNOLOGIES INC | October 05, 2018 | ? | ? |
View Kopp Family Office, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-16 |
View Kopp Family Office, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.